Prospective study of predictors of vitamin D status and cancer incidence and mortality in men

Journal of the National Cancer Institute

Volumn 98, Issue 7, 2006, Pages 451-459

  Giovannucci, Edward ^a,b   Liu, Yan ^b   Rimm, Eric B ^a,b   Hollis, Bruce W ^c   Fuchs, Charles S ^a,d   Stampfer, Meir J ^a,b   Willett, Walter C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; FOLIC ACID; RETINOL; VITAMIN D; HYDROXYCOLECALCIFEROL;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH PRACTITIONER; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DOCUMENTATION; MELANOMA; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; PHYSICAL ACTIVITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RISK REDUCTION; SKIN CANCER; SKIN PIGMENTATION; SUN EXPOSURE; SUNLIGHT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; DIGESTIVE SYSTEM TUMOR; INCIDENCE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; PREDICTION AND FORECASTING; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SURVIVAL; ULTRAVIOLET RADIATION; UNITED STATES;

ADULT; AGED; BODY MASS INDEX; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; HYDROXYCHOLECALCIFEROLS; INCIDENCE; LEISURE ACTIVITIES; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SKIN PIGMENTATION; SURVIVAL ANALYSIS; ULTRAVIOLET RAYS; UNITED STATES; VITAMIN D DEFICIENCY;

EID: 33645740073     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj101     Document Type: Article

References (49)

1. Peller S, Stephenson CS. Skin irritation and cancer in the United States Navy. Am J Med Sci 1937;194:326-33.
2. Apperly FL. The relation of solar radiation to cancer mortality in North American. Cancer Res 1941;1:191-5.
3. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
4. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation. Prev Med 1990;19:614-22.
5. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994;23:1133-6.
6. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990;10:13 07-11.
7. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer 1992;70:2861-9.
8. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-75.
9. Mizoue T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys 2004;87:532-8.
10. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005; 16:83-95.
11. Holick ME Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-71.
12. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135:317-22.
13. Chasan-Taber S, Rinun EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci E, et al. Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology 1996;7:81-6.
14. Clemens TL, Adams JS, Henderson SL, Holick ME Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982; 1:74-6.
15. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002;76:187-92.
16. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidermol 1992;135:1114-26.
17. Feskanich D, Rinim EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, et al, Reproducibility and validity of food intake measurements from a serniquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
18. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89:1196-9.
19. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
20. Rimin EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990;1:466-73.
21. Hollis BW, Kamerud JW, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioinummoassay using I[125]-labelled tracer. Clin Chem 1993;39:529-33.
22. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004;15:255-65.
23. Platz EA, Rimm. EB, Willett WC, Kantoff PW, Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 2000;92:2009-17.
24. Willett WC. Correction for the effects of measurement error. Nutritional epidemiology, 2nd edition. New York (NY): Oxford University Press; 1998, p. 302-20.
25. Rosner B, Willett WC, Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med 1989;8:1051-69.
26. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10.
27. Vieth R. The pharmacology of vitamin D, including fortification strategies. In Feldman D, Pike JW, Glorieux FH, editors. Vitamin D, 2nd edition. Amsterdam (The Netherlands): Elsevier Academic Press; 2005, p. 995-1015.
28. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387-91.
29. Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-23.
30. Newmark HL, Lipkin M, Maheshwari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J Nall Cancer Inst 1990;82:491-6.
31. Xue L, Lipkin M, Newmark H, Wang J. Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer hist 1999;91:176-81.
32. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, et al. Differentiation of mouse myeloid leukemia cells induced by 1[alpha], 25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 1981;78:4990-4.
33. Honma Y, Hozumi M, Abe E, Konno K, Fukushimia M, Hata S, et al. 1[alpha],25-dihydroxyvitamin D3 and 1[alpha]-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci U S A 1983;80:201-4.
34. Politzer WM. Long-term clinical remission of chronic lymphocytic leukaemia by dietary means. South African Med J 2005;95:321-2.
35. Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004; 15:149-58.
36. Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, et al. Vitamin D is associated with overall survival in early stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005;14:2303-9.
37. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 2005;65:5470-9.
38. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, et al. Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation. Cancer Lett 2003;200:141-8.
39. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989;2:1176-8.
40. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25.
41. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8.
42. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, et al. Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 1993;2:467-72.
43. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995;6:235-9.
44. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 1996;5:121-6.
45. Nomura AM, Stemmermann GN, Lee J, Kolonel IN, Chen TC, Turner A, et al. Sermn vitamin D metabolite levels and the subsequent development of prostate cancer. Cancer Causes Control 1998;9:425-32.
46. Jacobs ET, Giuliano AR, Martinez ME, Hollis BW, Reid ME, Marshall JR. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 2004; 89-90:533-7.
47. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-52.
48. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108:104-8.
49. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96.